Lutetium Lu-177

DB13982ApprovedInvestigationalSmall molecule

Lutetium Lu-177: Overview.

Chemical structure of Lutetium Lu-177
Mechanism
Curator reviewed
Formula / weight
Lu · 176.9438 g/mol (avg)
First approval
European Union, 2016
Also known as
177Lu · Lu 177 · Lu-177 · Lutetium Lu 177 · Lutetium-177
Brand names
  • Endolucinbeta
  • Illuzyce

Resolves to

Compound
UNIIBRH40Y9V1QCAS14265-75-9
Structure
InChIKeyOHSVLFRHMCKCQY-NJFSPNSNSA-NSMILES[177Lu]
Targets
Q04609FOLH1P30874SSTR2

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
92Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
19Marketed productsAcross 6 countries and 10 labellers
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Lutetium Lu-177, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In